Systemic Data Manipulation Uncovered at India’s Ipca Labs
The FDA has slammed yet another Indian drugmaker for data integrity issues: This time it rebuked Ipca Laboratories for data falsification at three of the company’s manufacturing facilities.
Source: Drug GMP Report